Skip to main content
Top
Published in: Endocrine 2/2017

01-11-2017 | Research Letter

Estimation of HbA1c in hospitalized patients with bronchial asthma

Authors: Bayar Qasim, Safer Haj, Herish Ahmed

Published in: Endocrine | Issue 2/2017

Login to get access

Excerpt

Asthma is a chronic inflammatory respiratory disease. It can affect people of any age, but often starts in childhood. It is characterized by attacks (also known as exacerbations) of breathlessness and wheezing, with the severity and frequency of attacks varying from person to person [1]. Stress hormones like cortisol and catecholamine’s may increase in stressful conditions like asthma and expected to induce hyperglycemia. Some anti-asthma medications increase blood glucose levels e.g. Beta-agonist, while others are known hyperglycemic agent’s e.g. steroids. However, most medications are administered through the inhalation route and are less likely to cause systemic endocrinometabolic effects [2]. …
Literature
2.
go back to reference U. Kapoor, G. Tayal, S. Mittal, V. Sharma, U. Tekur, Plasma cortisol levels in acute asthma. Indian J. Pediatr. 70, 965–968 (2003)CrossRefPubMed U. Kapoor, G. Tayal, S. Mittal, V. Sharma, U. Tekur, Plasma cortisol levels in acute asthma. Indian J. Pediatr. 70, 965–968 (2003)CrossRefPubMed
3.
go back to reference T. Nakazawa, Y. Umegae, S. Matsui, S. Kobayashi, Low plasma cortisol concentrations during late asthmatic responses. Br. Med. J. 291, 867–867 (1985)CrossRef T. Nakazawa, Y. Umegae, S. Matsui, S. Kobayashi, Low plasma cortisol concentrations during late asthmatic responses. Br. Med. J. 291, 867–867 (1985)CrossRef
4.
go back to reference K. Berkin, G. Walker, G. Inglis, S. Ball, N. Thomson, Circulating adrenaline and noradrenaline concentrations during exercise in patients with exercise induced asthma and normal subjects. Thorax 43, 295–299 (1988)CrossRefPubMedPubMedCentral K. Berkin, G. Walker, G. Inglis, S. Ball, N. Thomson, Circulating adrenaline and noradrenaline concentrations during exercise in patients with exercise induced asthma and normal subjects. Thorax 43, 295–299 (1988)CrossRefPubMedPubMedCentral
5.
go back to reference S. Genuth, K.G. Alberti, P. Bennett et al., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160–3167 (2003)CrossRefPubMed S. Genuth, K.G. Alberti, P. Bennett et al., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160–3167 (2003)CrossRefPubMed
6.
go back to reference K.K. Sato, T. Hayashi, N. Harita, T. Yoneda, Y. Nakamura, G. Endo, H. Kambe, Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 32, 644–646 (2009)CrossRefPubMedPubMedCentral K.K. Sato, T. Hayashi, N. Harita, T. Yoneda, Y. Nakamura, G. Endo, H. Kambe, Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care 32, 644–646 (2009)CrossRefPubMedPubMedCentral
7.
go back to reference Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007. J. Allergy Clin. Immunol. 120, S94-S138 (2007) Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma–Summary Report 2007. J. Allergy Clin. Immunol. 120, S94-S138 (2007)
8.
go back to reference M. Lutfi, M. Sukkar, The hyperglycemic effect of bronchial asthma. Sudan Med. J. 47, 69–74 (2011) M. Lutfi, M. Sukkar, The hyperglycemic effect of bronchial asthma. Sudan Med. J. 47, 69–74 (2011)
9.
go back to reference P. O’Byrne, S. Rennard, H. Gerstein, F. Radner, S. Peterson, B. Lindberg, L. Carlsson, D. Sin, Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir. Med. 106, 1487–1493 (2012)CrossRefPubMed P. O’Byrne, S. Rennard, H. Gerstein, F. Radner, S. Peterson, B. Lindberg, L. Carlsson, D. Sin, Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids. Respir. Med. 106, 1487–1493 (2012)CrossRefPubMed
10.
go back to reference R. Schellenberg, J. Adachi, D. Bowie, J. Brown, L. Guenther, T. Kader, G. Trope, Oral corticosteroids in asthma: a review of benefits and risks. Canad. Respir. J. 14, 1C–7C (2007)CrossRef R. Schellenberg, J. Adachi, D. Bowie, J. Brown, L. Guenther, T. Kader, G. Trope, Oral corticosteroids in asthma: a review of benefits and risks. Canad. Respir. J. 14, 1C–7C (2007)CrossRef
11.
go back to reference M. Lutfi, Effects of β2-agonist therapy on blood pressure, glycaemic control and electrolytes levels of asthmatic patients. Sudan J. Med. Sci. 6, 69–74 (2011) M. Lutfi, Effects of β2-agonist therapy on blood pressure, glycaemic control and electrolytes levels of asthmatic patients. Sudan J. Med. Sci. 6, 69–74 (2011)
12.
go back to reference B. Al-Shawwa, N. Al-Huniti, L. DeMattia et al., Asthma and insulin resistance in morbidly obese children and adolescents. J. Asthma 44, 469–473 (2007)CrossRefPubMed B. Al-Shawwa, N. Al-Huniti, L. DeMattia et al., Asthma and insulin resistance in morbidly obese children and adolescents. J. Asthma 44, 469–473 (2007)CrossRefPubMed
13.
go back to reference A. Agrawal, U. Mabalirajan, T. Ahmad, B. Ghosh, Emerging interface between metabolic syndrome and asthma. Am. J. Respir. Cell Mol. Biol. 44, 270–275 (2011)CrossRefPubMed A. Agrawal, U. Mabalirajan, T. Ahmad, B. Ghosh, Emerging interface between metabolic syndrome and asthma. Am. J. Respir. Cell Mol. Biol. 44, 270–275 (2011)CrossRefPubMed
14.
go back to reference A. Smith, J. Banks, K. Buchanan, B. Cheong, K. Gunawardena, Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. QJM: Int. J. Med. 82, 71–80 (1992) A. Smith, J. Banks, K. Buchanan, B. Cheong, K. Gunawardena, Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. QJM: Int. J. Med. 82, 71–80 (1992)
15.
go back to reference J. Molema, J. Lammers, C. van Herwaarden, H. Folgering, Effects of inhaled beclomethasone dipropionate on beta2-receptor function in the airways and adrenal responsiveness in bronchial asthma. Eur. J. Clin. Pharmacol. 34, 577–583 (1988)CrossRefPubMed J. Molema, J. Lammers, C. van Herwaarden, H. Folgering, Effects of inhaled beclomethasone dipropionate on beta2-receptor function in the airways and adrenal responsiveness in bronchial asthma. Eur. J. Clin. Pharmacol. 34, 577–583 (1988)CrossRefPubMed
16.
go back to reference A. Neville, J. Palmer, J. Gaddie, C. May, K. Palmer, L. Murchison, Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. Br. Med. J. 1, 413–414 (1977)CrossRefPubMedPubMedCentral A. Neville, J. Palmer, J. Gaddie, C. May, K. Palmer, L. Murchison, Metabolic effects of salbutamol: comparison of aerosol and intravenous administration. Br. Med. J. 1, 413–414 (1977)CrossRefPubMedPubMedCentral
17.
go back to reference J. Yernault, R. Leclercq, W. Schandevyl, E. Virasoro, A. De Coster, G. Copinschi, The endocrinometabolic effects of beclomethasone dipropionate in asthmatic patients. Chest 71, 698–702 (1977)CrossRefPubMed J. Yernault, R. Leclercq, W. Schandevyl, E. Virasoro, A. De Coster, G. Copinschi, The endocrinometabolic effects of beclomethasone dipropionate in asthmatic patients. Chest 71, 698–702 (1977)CrossRefPubMed
18.
go back to reference B. Thuesen, L. Husemoen, L. Hersoug, C. Pisinger, A. Linneberg, Insulin resistance as a predictor of incident asthma-like symptoms in adults. Clin. Exp. Allergy 39, 700–707 (2009)CrossRefPubMed B. Thuesen, L. Husemoen, L. Hersoug, C. Pisinger, A. Linneberg, Insulin resistance as a predictor of incident asthma-like symptoms in adults. Clin. Exp. Allergy 39, 700–707 (2009)CrossRefPubMed
19.
go back to reference R. Canis, S. Demirkok, Z. Osar, H. Balci, G. Can, Effects of inhaled budesonide on insulin sensitivity in nondiabetic patients with asthma and chronic obstructive pulmonary disease. Adv. Ther. 24, 560–570 (2007)CrossRefPubMed R. Canis, S. Demirkok, Z. Osar, H. Balci, G. Can, Effects of inhaled budesonide on insulin sensitivity in nondiabetic patients with asthma and chronic obstructive pulmonary disease. Adv. Ther. 24, 560–570 (2007)CrossRefPubMed
20.
go back to reference E. Gulcan, I. Bulut, A. Toker, A. Gulcan, Evaluation of glucose tolerance status in patients with asthma bronchiale. J. Asthma 46, 207–209 (2009)CrossRefPubMed E. Gulcan, I. Bulut, A. Toker, A. Gulcan, Evaluation of glucose tolerance status in patients with asthma bronchiale. J. Asthma 46, 207–209 (2009)CrossRefPubMed
Metadata
Title
Estimation of HbA1c in hospitalized patients with bronchial asthma
Authors
Bayar Qasim
Safer Haj
Herish Ahmed
Publication date
01-11-2017
Publisher
Springer US
Published in
Endocrine / Issue 2/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1395-1

Other articles of this Issue 2/2017

Endocrine 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine